Joint Filing AgreementJoint Filing Agreement • August 21st, 2014 • Biotechnology Value Fund L P • Investment advice
The undersigned hereby agree that the Amended Statement on Schedule 13G dated August 21, 2014 with respect to the shares of Common Stock of Ligand Pharmaceuticals Incorporated, and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
